These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 8656753)

  • 41. Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study.
    Mossong J; Putz L; Schneider F
    Epidemiol Infect; 2004 Jan; 132(1):11-8. PubMed ID: 14979584
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
    Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
    Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T; Baer M; Willems P
    Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of antibodies against measles, mumps and rubella in the childhood population in Singapore, 2008-2010.
    Ang LW; Lai FY; Tey SH; Cutter J; James L; Goh KT
    Epidemiol Infect; 2013 Aug; 141(8):1721-30. PubMed ID: 22999024
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of susceptibility to measles and rubella.
    Preblud SR; Gross F; Halsey NA; Hinman AR; Herrmann KL; Koplan JP
    JAMA; 1982 Feb; 247(8):1134-7. PubMed ID: 7057602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The determination of susceptibility to measles, rubella, mumps and chickenpox in students of health-related areas].
    Oliveira J; Dias N; Ferreira TM; da Cunha S; Costa D; Côrte-Real R; Meliço-Silvestre A
    Acta Med Port; 1999; 12(4-6):155-60. PubMed ID: 10481316
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Population-based case-control study of measles, mumps, and rubella and inflammatory bowel disease.
    Bernstein CN; Rawsthorne P; Blanchard JF
    Inflamm Bowel Dis; 2007 Jun; 13(6):759-62. PubMed ID: 17230540
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients.
    King SM; Saunders EF; Petric M; Gold R
    Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India.
    Gohil DJ; Kothari ST; Chaudhari AB; Gunale BK; Kulkarni PS; Deshmukh RA; Chowdhary AS
    Viral Immunol; 2016 Apr; 29(3):159-63. PubMed ID: 26910764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of antibodies to measles and rubella in Sana'a, Yemen.
    Sallam TA; Al-Jaufy AY; Al-Shaibany KS; Ghauth AB; Best JM
    Vaccine; 2006 Sep; 24(37-39):6304-8. PubMed ID: 16815602
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.
    Spoulou V; Giannaki M; Vounatsou M; Bakoula C; Grafakos S
    Bone Marrow Transplant; 2004 Jun; 33(12):1187-90. PubMed ID: 15077129
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
    J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunogenicity and reactogenicity of indigenously produced MMR vaccine.
    Bhargava I; Chhaparwal BC; Phadke MA; Irani SF; Chhaparwal D; Dhorje S; Maheshwari CP
    Indian Pediatr; 1995 Sep; 32(9):983-8. PubMed ID: 8935261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of measles, mumps, rubella, and varicella susceptibility among health science students in a University in India.
    Arunkumar G; Vandana KE; Sathiakumar N
    Am J Ind Med; 2013 Jan; 56(1):58-64. PubMed ID: 22467356
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants.
    D'Angio CT; Boohene PA; Mowrer A; Audet S; Menegus MA; Schmid DS; Beeler JA
    Pediatrics; 2007 Mar; 119(3):e574-9. PubMed ID: 17332177
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Measles, mumps, rubella: important health risks].
    Rev Infirm; 2000 Oct; (64):13-5. PubMed ID: 11288443
    [No Abstract]   [Full Text] [Related]  

  • 57. [Measles and mumps antibody concentrations in newborns and their mothers--follow up first year of life].
    Hohendahl J; Peters N; Hüttermann U; Rieger C
    Klin Padiatr; 2006; 218(4):213-20. PubMed ID: 16819702
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of a microquantity enzyme immunoassay in a large-scale study of measles, mumps and rubella immunity in Italy.
    Condorelli F; Stivala A; Gallo R; Marino A; Battaglini CM; Messina A; Russo G; Castro A; Scalia G
    Eur J Clin Microbiol Infect Dis; 1998 Jan; 17(1):49-52. PubMed ID: 9512184
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Humoral and cellular immunity to selected viral antigens in children from the Bełchatów Industrial Region].
    Stempień R; Słowińska I; Wardecka J; Deroń Z; Imbs D; Jankowski M; Jarzabek Z; Kańtoch M
    Med Dosw Mikrobiol; 1983; 35(3-4):259-68. PubMed ID: 6676608
    [No Abstract]   [Full Text] [Related]  

  • 60. [Value of salivary antibodies for determining seropositivity to measles, rubella, and mumps in children and adults].
    Garrido Redondo M; Blanco Quirós A; Garrote Adrados JA; Tellería Orriols JJ; Arranz Sanz E
    An Esp Pediatr; 1997 Nov; 47(5):499-504. PubMed ID: 9586291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.